Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

By C. Polman, S. Reingold, G. Edan, M. Filippi, H. Hartung, L. Kappos, F. Lublin, L. Metz, H. McFarland, P. O'Connor and 4 more. Annals of Neurology, 2005

5,239 citations recorded by the source corpus.

Subfields: Neurology, Pathology and Forensic Medicine, Rheumatology

View Paper: https://www.semanticscholar.org/paper/c2294f4290df6157be845d7d13144e56f8dca90b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Neurology

1. Patrik Vuilleumier
2. B. Weinshenker

In Pathology and Forensic Medicine

1. Jeffrey A. Cohen
2. B. Weinshenker

Citations in the corpus

• Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. (2012, neutral): “Multiple sclerosis relapse 60 (15) 39 (10) 32 (8)”
• Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS) (2011, background): “The drug was cautiously re-introduced in 2006 after safety review, under a special prescription and observation programme, as the clinical benefits in people with aggressive RRMS are judged to outweigh the risks (Polman et al., 2006; Goodin et al., 2008).”
• Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis (2008, methodology): “time and space is capable of establishing the possible conversion of a CIS into a CDMS.(20)”
• Diffusion Tensor Imaging of Post Mortem Multiple Sclerosis Brain (2006, neutral): “…for free, on ScienceDirect. ent Sponsored D ocum ent Sponsored D ocum ent techniques often summarized as “conventional”) magnetic resonance imaging (MRI) displays MS white matter (WM) lesions (WMLs) with high sensitivity and is helpful in diagnosis (McDonald et al., 2001; Polman et al., 2005).”
• Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria (2011, methodology): “Although the diagnosis can be made on clinical grounds alone, magnetic resonance imaging (MRI) of the central nervous system (CNS) can support, supplement, or even replace some clinical criteria,3–9 as most recently emphasized by the so-called McDonald Criteria of the International Panel on Diagnosi”
• Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis. (2012, neutral): “Back pain 33 (9) 35 (10) 36 (10) 32 (9)”
• Principal components of functional connectivity: A new approach to study dynamic brain connectivity during rest (2013, methodology): “RRMS patients were diagnosed according to McDonald's criteria (Polman et al., 2005) and selected using criteria for 1) mild to moderate neurological disability with no impaired ambulation (Expanded Disability Status Scale (EDSS) ≤ 2.”